NovaBay Pharmaceuticals, Inc. NBY Open NovaBay Pharmaceuticals, Inc. in new tab
NovaBay Pharmaceuticals, Inc. Analysis (NBY)
Is NovaBay Pharmaceuticals, Inc. a good investment? NovaBay Pharmaceuticals, Inc. (NBY) is currently trading at 1.95 USD. Market analysts have a consensus price target of 3.73 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 0.05. This relatively low multiple may signal that NovaBay Pharmaceuticals, Inc. is undervalued compared to historical market norms.
Earnings Schedule: NovaBay Pharmaceuticals, Inc. is expected to release its next earnings report on April 1, 2026. The market consensus estimate for Forward EPS is -0.82.
For income investors, NovaBay Pharmaceuticals, Inc. pays a dividend yield of 41.03%. With a payout ratio of -22%, the dividend appears sustainable.
Investor FAQ
Does NovaBay Pharmaceuticals, Inc. pay a dividend?
Yes, it pays an annual dividend of 0.80 USD (41.03% yield).
What asset class is NovaBay Pharmaceuticals, Inc.?
NovaBay Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be April 1, 2026. The company currently has a trailing EPS of -28.50.
Company Profile
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Dividend Yield
41.03%
Annual Dividends
0.80 USD
Next ex. div date
Sept. 30, 2025
Payout Ratio
-21.76%
Historical Dividends
| Year | Total Dividends |
|---|---|
| 2025 | 0.16 USD |
| Sept. 30, 2025 | 0.1600 |
Yearly aggregated dividends
Dividends
|
NovaBay Pharmaceuticals, Inc.
Sep 30, 2025 Paid
Dividend
0.16 USD |
Historical Split Corporate Actions
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 21, 2015 | 0.040000 |
| Nov. 16, 2022 | 0.030000 |
| May 31, 2024 | 0.030000 |
| Feb. 23, 2026 | 0.200000 |
Explore Premium Features
Unlock detailed news and exclusive insights with our Premium subscription.
See Pricing Plans
Community Discussion